Legal literacy
Legal status and risk
“Research use only” is a labeling and marketing category, not a permission slip. This page explains what the category means, what it forbids, and where the real exposure sits.
What the label means
A product labeled “research use only” (RUO) is represented by its seller as a laboratory reagent - intended for in vitro or non-clinical laboratory work, not for diagnosis, treatment, or consumption by humans or animals. The label describes the seller's stated intended use. It does not certify identity, purity, sterility, or safety, and it does not create a legal category of person who may lawfully consume the material.
What it does not permit
- It does not make a substance lawful to sell for human use. Marketing an RUO material with claims about treating, preventing, or improving a condition can render it an unapproved new drug and a misbranded or adulterated product under the Federal Food, Drug, and Cosmetic Act.
- It does not exempt controlled substances. If a compound is scheduled under the Controlled Substances Act, or is an analogue treated as scheduled, RUO labeling is irrelevant to that status.
- It does not authorize compounding. Several peptides have been designated by the FDA as ineligible for pharmacy compounding pending further study.
- It does not override import law. Customs seizure, refusal, and destruction of imported RUO material are routine, and import for personal use is a separate legal question from import as a reagent.
- It does not shield anyone from liability. Injury arising from human use of a reagent can create civil exposure for the user, the seller, and any intermediary.
Where the risk actually is
Material risk
Wrong sequence, low purity, residual solvents, heavy metals, bacterial endotoxin, non-sterile fill, and inaccurate stated mass. Without an independent assay, a certificate of analysis is an assertion, not evidence.
Health risk
Unknown pharmacology, no established safety margin, immunogenicity, contamination-related infection, and interactions that no one has characterized. Absence of published harm is not evidence of safety.
Legal risk
Misbranding and unapproved-drug exposure for sellers; controlled-substance exposure where scheduling applies; import seizure; professional licensing consequences for clinicians.
Documentation risk
Undocumented work cannot be reviewed, replicated, or defended. Poor records are the difference between a finding and an anecdote.
The Foundation's position
The Foundation does not sell, supply, broker, or recommend research materials, and it does not certify anyone to consume them. Its credential attests to training in chemistry, verification, handling, documentation, and legal limits. Where the evidence base is thin, the correct answer is to say so - and to build the structured record that would let legitimate clinical investigation proceed. See mission and governance.